Cargando…

A First Draft of the History of Treating Coronavirus Disease 2019: Use of Repurposed Medications in United States Hospitals

Detalles Bibliográficos
Autores principales:	Clancy, Cornelius J, Nguyen, M Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798557/ https://www.ncbi.nlm.nih.gov/pubmed/33553472 http://dx.doi.org/10.1093/ofid/ofaa617

Ejemplares similares

Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
por: Buehrle, Deanna J, et al.
Publicado: (2020)

Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March–May 2020
por: Kadri, Sameer S, et al.
Publicado: (2020)

Shelter Hospital: Glimmers of Hope in Treating Coronavirus 2019
por: Zhou, Feng, et al.
Publicado: (2020)

Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?
por: Vassileva, Snejina, et al.
Publicado: (2021)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Thromboprophylaxis for medical inpatients with coronavirus disease 2019
por: Dalager-Pedersen, M., et al.
Publicado: (2020)

First Case of 2019 Novel Coronavirus in the United States
por: Holshue, Michelle L., et al.
Publicado: (2020)

The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States
por: Moghadas, Seyed M, et al.
Publicado: (2021)

Treating Gastrointestinal Cancer During the Coronavirus Disease 2019 Pandemic in Europe
por: Collienne, Maike, et al.
Publicado: (2020)

Therapeutic potential of inhalable medications to combat coronavirus disease-2019
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Perspectives for repurposing drugs for the coronavirus disease 2019
por: Cherian, Sarah S., et al.
Publicado: (2020)

Buying Time: The AMR Action Fund and the State of Antibiotic Development in the United States 2020
por: Clancy, Cornelius J, et al.
Publicado: (2020)

Buying time: Drug repurposing to treat the host in COVID‐19H
por: Martin, Jennifer H., et al.
Publicado: (2020)

Topological network based drug repurposing for coronavirus 2019
por: Habibi, Mahnaz, et al.
Publicado: (2021)

Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States
por: Kapoor, Minal, et al.
Publicado: (2014)

Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators
por: Talbot, H Keipp, et al.
Publicado: (2021)

Proposal for Coronavirus Disease 2019 Management
por: Downs, John B., et al.
Publicado: (2020)

Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies
por: Clancy, Cornelius J, et al.
Publicado: (2021)

Commentary: Patients first with physicians safe: Controlled apneic tracheostomy in patients with coronavirus disease 2019 (COVID-19)
por: Omer, Shuab, et al.
Publicado: (2020)

779. Impact of updated IDSA practice guidelines on the treatment of Clostridium difficile infections in the United States
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
por: Geisler, Benjamin P., et al.
Publicado: (2020)

Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review
por: Geisler, Benjamin P., et al.
Publicado: (2021)

Coronavirus 2019, Microthromboses, and Platelet Activating Factor
por: Theoharides, Theoharis C., et al.
Publicado: (2020)

Return of the Coronavirus: 2019-nCoV
por: Gralinski, Lisa E., et al.
Publicado: (2020)

Clinical Distancing and Mitigation of Coronavirus Disease 2019
por: Scott, Benjamin K., et al.
Publicado: (2020)

Commentary: The molecular pandemonium of coronavirus disease 2019
por: Balsam, Leora B., et al.
Publicado: (2021)

Is It Time for Coronavirus Disease-2019 Vaccine Mandates?
por: Bernstein, Henry H., et al.
Publicado: (2022)

Which are the best coronavirus disease 2019 vaccines?
por: Omrani, Ali S., et al.
Publicado: (2021)

Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter
por: Buehrle, Deanna J., et al.
Publicado: (2020)

Cancer patients and coronavirus disease 2019: evidence in context
por: Barba, Maddalena, et al.
Publicado: (2020)

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
por: Beer, Karlyn D., et al.
Publicado: (2020)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Preparedness for further boosting coronavirus disease 2019 vaccines
por: Lim, So Yun, et al.
Publicado: (2022)

Repurposing biomedical informaticians for COVID-19
por: Sosa, Daniel N., et al.
Publicado: (2021)

Repurposing Belinostat for Alleviation of Atopic Dermatitis
por: Quah, Shan, et al.
Publicado: (2021)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

Patients With Lung Cancer and Coronavirus Disease 2019 Epidemic: An Experience From an Italian University Hospital
por: Scagliotti, Giorgio, et al.
Publicado: (2020)

Medical Licensure: It Is Time to Eliminate Practice Borders Within the United States
por: Sawalha, Amr H.
Publicado: (2020)

Implications of current and future approaches to coronavirus disease 2019 testing
por: Smith, Rasheid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5m5ekjroslo7bi291j2l8ossnt